PSNPrescribable
methylphenidate 17.3 MG Extended Release Disintegrating Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Cotempla Xr-odt Tablet, Orally Disintegrating
RxNorm Crosswalk NDC 70165-200
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Cotempla Xr-odt (NDC 70165-200) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 6 unique RxNorm concepts. By anchoring Neos Therapeutics Brands, Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
methylphenidate 17.3 MG Disintegrating Oral Tablet
(RxCUI 1926840)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Cotempla XR-ODT 17.3 MG Extended Release Disintegrating Oral Tablet
(RxCUI 1926847)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
methylphenidate 25.9 MG Disintegrating Oral Tablet
(RxCUI 1926849)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Cotempla XR-ODT 25.9 MG Extended Release Disintegrating Oral Tablet
(RxCUI 1926851)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
methylphenidate 8.6 MG Disintegrating Oral Tablet
(RxCUI 1926853)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet
(RxCUI 1926855)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Cotempla Xr-odt
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 70165-200 to RxCUI 1926840, 1926847, 1926849, 1926851, 1926853, 1926855, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
* Please review the full disclaimer at the bottom of this page.
